$LMAT
LEMAITRE VASCULAR INC Stock $lmat

$lmat Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921011509 Filed on May 10, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$35.88M	$30.55M
YoY Change	17.45%	7.28%
Cost Of Revenue	$12.08M	$10.07M
YoY Change	20.02%	11.68%
Gross Profit	$23.80M	$20.48M
YoY Change	16.19%	5.24%
Gross Profit Margin	66.32%	67.05%
Selling, General & Admin	$13.01M	$13.14M
YoY Change	-0.96%	2.71%
% of Gross Profit	54.67%	64.13%
Research & Development	$2.844M	$2.994M
YoY Change	-5.01%	33.66%
% of Gross Profit	11.95%	14.62%
Depreciation & Amortization	$2.624M	$1.538M
YoY Change	70.61%	19.78%
% of Gross Profit	11.03%	7.51%
Operating Expenses	$15.85M	$16.13M
YoY Change	-1.71%	7.33%
Operating Profit	$7.945M	$4.353M
YoY Change	82.52%	-1.85%
Interest Expense	$577.0K	$0.00
YoY Change		-100.0%
% of Operating Profit	7.26%	0.0%
Other Income/Expense, Net
YoY Change
Pretax Income	$7.493M	$4.280M
YoY Change	75.07%	-5.16%
Income Tax	$1.564M	$1.106M
% Of Pretax Income	20.87%	25.84%
Net Earnings	$5.929M	$3.174M
YoY Change	86.8%	-9.65%
Net Earnings / Revenue	16.52%	10.39%
Basic Earnings Per Share	$0.29	$0.16
Diluted Earnings Per Share	$0.28	$0.16
COMMON SHARES
Basic Shares Outstanding	20.55M	20.17M
Diluted Shares Outstanding	20.85M	20.44M

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.70M	$30.60M
YoY Change	-22.55%	-35.58%
Cash & Equivalents	$23.53M	$10.94M
Short-Term Investments	$200.0K	$19.70M
Other Short-Term Assets	$7.500M	$7.100M
YoY Change	5.63%	39.22%
Inventory	$39.20M	$35.40M
Prepaid Expenses
Receivables	$20.13M	$16.63M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$90.66M	$89.72M
YoY Change	1.04%	-5.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.20M	$14.79M
YoY Change	2.77%	4.83%
Goodwill	$65.95M	$39.77M
YoY Change	65.8%	33.11%
Intangibles	$57.34M	$24.06M
YoY Change	138.33%	82.56%
Long-Term Investments
YoY Change
Other Assets	$1.110M	$260.0K
YoY Change	326.92%	23.81%
Total Long-Term Assets	$156.7M	$94.84M
YoY Change	65.25%	46.27%
TOTAL ASSETS
Total Short-Term Assets	$90.66M	$89.72M
Total Long-Term Assets	$156.7M	$94.84M
Total Assets	$247.4M	$184.6M
YoY Change	34.03%	15.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.561M	$1.381M
YoY Change	85.45%	-42.0%
Accrued Expenses	$14.37M	$11.02M
YoY Change	30.41%	-17.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.800M
YoY Change
Total Short-Term Liabilities	$22.30M	$16.59M
YoY Change	34.39%	-14.4%
LONG-TERM LIABILITIES
Long-Term Debt	$28.50M	$0.00
YoY Change
Other Long-Term Liabilities	$4.575M	$4.237M
YoY Change	7.98%	108.51%
Total Long-Term Liabilities	$4.575M	$4.237M
YoY Change	7.98%	108.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.30M	$16.59M
Total Long-Term Liabilities	$4.575M	$4.237M
Total Liabilities	$69.84M	$35.72M
YoY Change	95.52%	31.5%
SHAREHOLDERS EQUITY
Retained Earnings	$74.22M	$58.29M
YoY Change	27.34%	22.26%
Common Stock	$117.5M	$107.2M
YoY Change	9.61%	7.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$11.69M	$11.09M
YoY Change	5.42%	6.93%
Treasury Stock Shares	$1.541M	$1.524M
Shareholders Equity	$177.5M	$148.8M
YoY Change
Total Liabilities & Shareholders Equity	$247.4M	$184.6M
YoY Change	34.03%	15.17%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$5.929M	$3.174M
YoY Change	86.8%	-9.65%
Depreciation, Depletion And Amortization	$2.624M	$1.538M
YoY Change	70.61%	19.78%
Cash From Operating Activities	$6.074M	$1.189M
YoY Change	410.85%	-642.92%
INVESTING ACTIVITIES
Capital Expenditures	-$1.060M	-$860.0K
YoY Change	23.26%	7.5%
Acquisitions	$0.00	$59.00K
YoY Change	-100.0%
Other Investing Activities	$0.00	$840.0K
YoY Change	-100.0%	-107.67%
Cash From Investing Activities	-$1.060M	-$25.00K
YoY Change	4140.0%	-99.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$1.297M	-$176.0K
YoY Change	636.93%	-61.49%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$7.965M	-$1.741M
YoY Change	357.5%	-510.61%
NET CHANGE
Cash From Operating Activities	$6.074M	$1.189M
Cash From Investing Activities	-$1.060M	-$25.00K
Cash From Financing Activities	-$7.965M	-$1.741M
Net Change In Cash	-$3.239M	-$842.0K
YoY Change	284.68%	-92.71%
FREE CASH FLOW
Cash From Operating Activities	$6.074M	$1.189M
Capital Expenditures	-$1.060M	-$860.0K
Free Cash Flow	$7.134M	$2.049M
YoY Change	248.17%	252.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20606789
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	646000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	623000	USD
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	37000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	37000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22131423
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22061554
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1540813
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1538572
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23525000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26764000	USD
CY2021Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	214000	USD
CY2020Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	214000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20126000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19552000	USD
CY2021Q1	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	45071000	USD
CY2020Q4	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	45115000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1721000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2618000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	90657000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	94263000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15200000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15036000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15478000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16066000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	65945000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	65945000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	57339000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	58905000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1640000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1686000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1110000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	909000	USD
CY2021Q1	us-gaap	Assets Assets	247369000	USD
CY2020Q4	us-gaap	Assets Assets	252810000	USD
CY2021Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	2750000	USD
CY2020Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	2500000	USD
CY2021Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2020Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2561000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2394000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14365000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17525000	USD
CY2021Q1	lmat	Acquisition Related Obligations AcquisitionRelatedObligations	776000	USD
CY2020Q4	lmat	Acquisition Related Obligations AcquisitionRelatedObligations	772000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1848000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1954000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	22300000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25145000	USD
CY2021Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	28485000	USD
CY2020Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	35532000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14360000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14791000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	124000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	127000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4575000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4643000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	69844000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	80238000	USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	221000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	221000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	117236000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	114924000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	74221000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	70554000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2463000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1525000	USD
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	11690000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11602000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	177525000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	172572000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	247369000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	252810000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	35883000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	30551000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12084000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10068000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	23799000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	20483000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6466000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7945000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1656000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	148141000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3174000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6544000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5191000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2844000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2994000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	15854000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	16130000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7945000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4353000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	105000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	577000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	-0	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	124000	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-178000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7493000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4280000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1564000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1106000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5929000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3174000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20546000
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20168000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20847000
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20438000
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.110
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.095
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5929000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3174000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-937000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1208000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-310000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-938000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1518000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4991000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1518000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	233000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	57000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	779000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1917000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	148835000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	172572000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5929000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-938000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1385000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2985000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	88000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	927000	USD
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2262000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	177525000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5929000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3174000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2624000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1538000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	927000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	779000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	47000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	64000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	59000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	71000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	1005000	USD
CY2020Q1	us-gaap	Inventory Write Down InventoryWriteDown	196000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-33000	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-208000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	857000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	368000	USD
CY2021Q1	lmat	Increase Decrease In Inventory And Other Deferred Costs IncreaseDecreaseInInventoryAndOtherDeferredCosts	1346000	USD
CY2020Q1	lmat	Increase Decrease In Inventory And Other Deferred Costs IncreaseDecreaseInInventoryAndOtherDeferredCosts	1861000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-638000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-659000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-3271000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6074000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1189000	USD
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1059000	USD
CY2020Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	863000	USD
CY2021Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1000	USD
CY2020Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2103000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3000000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	59000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1060000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-7000000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1385000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	233000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	88000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	57000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2262000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1917000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7965000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1741000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-288000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-265000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3239000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-842000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26764000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11786000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23525000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10944000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30551000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5044000	USD
CY2021Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	7586000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	6004000	USD
CY2021Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	26483000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	28117000	USD
CY2021Q1	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	5834000	USD
CY2020Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	5950000	USD
CY2021Q1	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	45071000	USD
CY2020Q4	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	45115000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35883000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	789000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	820000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	31000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	789000	USD
CY2021Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5168000	USD
CY2021Q1	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	1900000	USD
CY2020Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	2100000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	74243000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16904000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	57339000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	74243000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15338000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	58905000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1566000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	834000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4613000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5975000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5902000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5706000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5467000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5001000	USD
CY2021Q1	us-gaap	Secured Debt SecuredDebt	31235	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	607000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	474000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	64000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	13000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	671000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	487000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	748000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	591000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	149000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y7M6D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0502	pure
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0525	pure
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2031000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2439000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2066000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1869000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1919000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1977000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7954000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4047000	USD
CY2021Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	161000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	39000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4588000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6417000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14365000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17525000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	16208000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5880000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8675000	USD
CY2021Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	3736000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2394000	USD
CY2021Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	3678000	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	3700000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	765000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	813000	USD
CY2021Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	132000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	130000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4575000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4643000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	779000	USD
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	35883000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	30551000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	927000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	927000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	779000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	694
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2100
CY2021Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	70000
CY2020Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	23000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5929000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3174000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20546000
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20168000
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5929000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3174000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20546000
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20168000
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	301000
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	270000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20847000
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20438000
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	256000
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	468000
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	337000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	526000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2240000	USD
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1765000	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2020Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-0	USD
CY2020Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-0	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-30000	USD
CY2020Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-28000	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2270000	USD
CY2020Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1793000	USD

Files In Submission

Name	View Source	Status
0001437749-21-011509-index-headers.html	Edgar Link	pending
0001437749-21-011509-index.html	Edgar Link	pending
0001437749-21-011509.txt	Edgar Link	pending
0001437749-21-011509-xbrl.zip	Edgar Link	pending
ex_245339.htm	Edgar Link	pending
ex_245340.htm	Edgar Link	pending
ex_245341.htm	Edgar Link	pending
ex_245342.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lmat-20210331.xsd	Edgar Link	pending
lmat-20210331_cal.xml	Edgar Link	unprocessable
lmat-20210331_def.xml	Edgar Link	unprocessable
lmat-20210331_lab.xml	Edgar Link	unprocessable
lmat-20210331_pre.xml	Edgar Link	unprocessable
lmat20210331_10q.htm	Edgar Link	pending
lmat20210331_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LMAT
LEMAITRE VASCULAR INC Stock $lmat

2021 Q1 Form 10-Q Financial Statement

#000143774921011509 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMAT LEMAITRE VASCULAR INC Stock $lmat

2021 Q1 Form 10-Q Financial Statement

#000143774921011509 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMAT
LEMAITRE VASCULAR INC Stock $lmat